Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v24-FR Version v18-FR
Language French French
Date Updated 2020-10-26 2019-02-15
Drug Identification Number 02440210 02440210
Brand name NAT-LEVETIRACETAM NAT-LEVETIRACETAM
Common or Proper name LEVETIRACETAM Tablets LEVETIRACETAM Tablets
Company Name NATCO PHARMA (CANADA) INC NATCO PHARMA (CANADA) INC
Ingredients LEVETIRACETAM LEVETIRACETAM
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 120 120
ATC code N03AX N03AX
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Requirements related to complying with good manufacturing practices. Shortage of an active ingredient.
Anticipated start date 2018-09-26 2018-09-26
Actual start date 2018-09-26 2018-09-26
Estimated end date Unknown Unknown
Actual end date 2020-10-08
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments API provided by Hetero Labs Unit 1, which received non-compliant letter Feb. 12, 2019
Health Canada comments